Harry Erba, MD, PhD; Duke University; 5Live #ASH20

6:29

Key insights from the 2020 Annual Hematology meeting in Leukemia

Acute Myeloid Leukemia

Key insights from the 2020 Annual Hematology meeting in Leukemia

Acute Myeloid Leukemia Similar Videos

Similar Videos

Advances in biomarker-driven therapy in AML_Eunice Wang, MD; #BeyondASCO

15:08
AML in the Elderly- Is there a standard of care?_Martha Arellano, MD; #DDHO2021

3:49
New Directions in the Treatment of Relapsed and Refractory AML_Gail Roboz, MD; #hemeupdates2022

12:35

ABOUT

Bio Ascend is an independent medical education company committed to supporting healthcare providers in their efforts to translate innovative science into clinical practice.

The Bio Ascend team has deep oncology and hematology expertise with a proven ability to distill complex scientific ideas into their essential components, as well as extensive experience in planning, executing, and assessing meaningful education for clinicians.

CONNECT

support@bioascend.com

(888) 476-9129

980 North Michigan Avenue, Suite 1400, Chicago, IL 60611